| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 04/20/2011 | CN102018762A Quality control method for Chinese medicinal preparation |
| 04/20/2011 | CN102018760A Traditional Chinese medicine for treating benign prostatic hyperplasia |
| 04/20/2011 | CN102018757A Traditional Chinese medicine for treating eyeground pathological changes caused by diabetes |
| 04/20/2011 | CN102018736A Natural indigo decoction piece and preparation method thereof |
| 04/20/2011 | CN102018718A Application of Xanthoceraside compound |
| 04/20/2011 | CN102018715A Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 04/20/2011 | CN102018704A Compound preparation used for treating chronic kidney diseases and preparation method thereof |
| 04/20/2011 | CN102018702A New application of ginkgolide B |
| 04/20/2011 | CN102018689A New application of curcumin |
| 04/20/2011 | CN102018685A Terazosin pellicle and preparation method thereof |
| 04/20/2011 | CN102018660A Naftopidil suppository and preparation method thereof |
| 04/20/2011 | CN102018655A Transdermal medicament delivery combined preparation |
| 04/20/2011 | CN101579412B Medicinal composition for treating prostatauxe and preparation method thereof |
| 04/20/2011 | CN101564461B Method for preparing Chinese medicine used for clearing heat, moistening lung, relieving cough, resolving phlegm, disinhibiting urine and freeing strangury |
| 04/20/2011 | CN101560178B Polysubstituted indoline compound, preparation method and medical application thereof |
| 04/20/2011 | CN101524412B Traditional Chinese medicine composition for treating kidney failure and preparation method thereof |
| 04/20/2011 | CN101480424B Medicine for treating prostatosis and method for preparing same |
| 04/20/2011 | CN101433589B Oral Chinese medicine decoction for treating primary enuresis symptoms of children |
| 04/20/2011 | CN101417971B Indolines compounds, preparation method and pharmaceutical application thereof |
| 04/20/2011 | CN101269165B Medicament for treating stomach, sausage and nephrocolic |
| 04/20/2011 | CN101254279B Health care traditional Chinese medicine |
| 04/20/2011 | CN101229292B Chinese traditional medicine preparation for treating nephropathy, preparation method and applications thereof |
| 04/20/2011 | CN101199534B Anti-tumor function of raw panoxadiol derivative |
| 04/20/2011 | CN101167728B Doxazosin-mesylate controlled-releasing tablet and preparation method thereof |
| 04/20/2011 | CN101161646B Ketones compound preventing cells from oxidation damage, preparation method and uses thereof |
| 04/20/2011 | CN101108202B Flush fluid for urinary bladder and its preparation method |
| 04/20/2011 | CN101095681B Alfuzosin Hydrochloride permeating pump type controlled-release preparation and method for preparing the same |
| 04/20/2011 | CN101069692B Medicine preparation containing centella triterpenic genine and preparing method thereof |
| 04/19/2011 | US7928255 Intermediates for the preparation of lipoxin A4 analogs |
| 04/19/2011 | US7928219 chemically modified nucleic acid molecule; cancer; carcinoma, neovascularization, diabetic retinopathy, neovascular glaucoma, myopic degeneration and other proliferative diseases, restenosis and polycystic kidney disease |
| 04/19/2011 | US7928218 Treatment of any disease that responds to modulation of gene expression, for example cancer, proliferative, inflammatory, metabolic, autoimmune, neurologic, ocular diseases; in vivo stability and bioavailability |
| 04/19/2011 | US7928125 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 04/19/2011 | US7928124 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 04/19/2011 | US7928037 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide |
| 04/19/2011 | US7927806 Distinguishing PCA3 messenger RNA species in benign and malignant prostate tissues |
| 04/19/2011 | US7927622 Methods of transnasal transport/immunization with highly adaptable carriers |
| 04/19/2011 | CA2503570C Remedy for overactive bladder comprising acetic acid anilide derivative as the active ingredient |
| 04/19/2011 | CA2486495C 9-alpha-substituted estratrienes as selectively active estrogens |
| 04/19/2011 | CA2476012C Substituted pyridinones as modulators of p38 map kinase |
| 04/19/2011 | CA2458452C Gnrh agonist combination drugs |
| 04/14/2011 | WO2011044105A1 Treatment with cholinergic agonists |
| 04/14/2011 | WO2011043371A1 Oxazole compound |
| 04/14/2011 | WO2011043147A1 Cell preparation for erectile dysfunction or urinary incontinence containing adipose tissue derived mesenchymal stem cells |
| 04/14/2011 | WO2011043136A1 Immunosuppressing agent comprising mesenchymal stem cell derived from adipose tissue, and use thereof |
| 04/14/2011 | WO2011002161A3 Transdermal composition comprising tolterodine |
| 04/14/2011 | WO2010140832A3 Pharmaceutical composition containing herbal extracts for preventing or treating nephritis |
| 04/14/2011 | US20110086893 Oxa- and thiadiazoles and their use as metalloproteinase inhibitors |
| 04/14/2011 | US20110086857 N-((1r,2s,5r)-5-(tert-butylamino)-2-((s)-3-(7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes |
| 04/14/2011 | US20110086849 novel benzoxazine benzimidazole derivative, a pharmaceutical composition comprising the same, and ause thereof |
| 04/14/2011 | US20110086843 Thiazole Derivatives and Use Thereof |
| 04/14/2011 | US20110086830 Metal complexes of n-heterocyclic carbenes |
| 04/14/2011 | US20110086103 Novel mandelate salt of fesoterodine |
| 04/14/2011 | US20110086097 Manufacture process for the preparation of an iron containing phosphate adsorbent |
| 04/14/2011 | US20110086050 Glycoprotein compositions |
| 04/14/2011 | CA2776971A1 Treatment with cholinergic agonists |
| 04/14/2011 | CA2774992A1 Combination therapy using a beta 3 adrenergic receptor agonist and an antimuscarinic agent |
| 04/13/2011 | EP2309261A1 Methods for evaluating tissue morphogenesis and morphogenic activity |
| 04/13/2011 | EP2308963A2 System for processing lipoaspirate cells |
| 04/13/2011 | EP2308880A1 Tetracyclic compound |
| 04/13/2011 | EP2308855A1 2,4-Diaminopyrimidine derivatives |
| 04/13/2011 | EP2308846A2 Caspase inhibitors and uses thereof |
| 04/13/2011 | EP2308845A2 Caspase inhibitors and uses thereof |
| 04/13/2011 | EP2308844A2 Caspase inhibitors and uses thereof |
| 04/13/2011 | EP2308591A1 Adsorbent, cleansing agent, remedy for kidney disease and functional food |
| 04/13/2011 | EP2308562A2 Azetidine ring compounds and drugs comprising the same |
| 04/13/2011 | EP1539763B1 Azaindole kinase inhibitors |
| 04/13/2011 | CN1882547B 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 04/13/2011 | CN102015697A Amide derivative and pharmaceutical composition containing the same |
| 04/13/2011 | CN102015685A Substituted dihydropyrazolones as inhibitors of HIF-prolyl-4-hydroxylases |
| 04/13/2011 | CN102015638A Long-chain fatty acid elongation enzyme inhibitor comprising arylsulfonyl derivative as active ingredient |
| 04/13/2011 | CN102015637A Novel phenylpyrrole derivative |
| 04/13/2011 | CN102015026A Novel nip thiazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
| 04/13/2011 | CN102014657A Soybean protein material for patients with renal disease and foods made from the same |
| 04/13/2011 | CN102008702A Externally-applied traditional Chinese medicine composition for treating child bed-wetting |
| 04/13/2011 | CN102008697A Medicinal liquor for curing nephropathy and preparation method thereof |
| 04/13/2011 | CN102008669A Traditional Chinese medicine formula for treating chyluria |
| 04/13/2011 | CN102008660A Formula of kidney-nourishing medicinal liquor |
| 04/13/2011 | CN102008569A Traditional Chinese medicine preparation for treating chronic prostatitis |
| 04/13/2011 | CN102008567A Novel decoction preparation (novel drug delivery system) for discharging blood clots and preparation method thereof |
| 04/13/2011 | CN102008533A Medicinal application and preparation method of shorthorned epimedium P.E |
| 04/13/2011 | CN102008514A Traditional Chinese medicinal preparation and preparation method and applications thereof |
| 04/13/2011 | CN102008474A Application of nitidine chloride to preparation of medicament for resisting autoimmunity disease and graft versus host disease |
| 04/13/2011 | CN102008468A Application of Incarvillea delavay alkali in preparing drug for resisting autoimmune diseases and graft rejection diseases |
| 04/13/2011 | CN102008446A 吡非尼酮固体分散体及其制剂 Pirfenidone solid dispersion and its preparations |
| 04/13/2011 | CN102008439A Curcumin coated liposome preparation and preparation method thereof |
| 04/13/2011 | CN102008431A Double-layer moxifloxacin suppository and preparation method thereof |
| 04/13/2011 | CN101716314B Orally taken traditional Chinese medicine composite for treating bladder cancer |
| 04/13/2011 | CN101596171B Tamsulosin sustained release tablet and preparation method thereof |
| 04/13/2011 | CN101461804B (+)-1-(3,4-dichlorrophenyl)-3-azabicyclo[3.1.0]hexane, compositions and uses thereof |
| 04/13/2011 | CN101455675B Ferulaic acid and astragaloside combination for treating and preventing renal interstitial fibrosis, and preparation method and use thereof |
| 04/13/2011 | CN101444496B Compounds for the treatment of metabolic disorders |
| 04/13/2011 | CN101313971B Chinese medicine composition for treating nephropathy |
| 04/13/2011 | CN101233942B Method for cooking medicinal diet kidney-tonifying yang-invigorating soup |
| 04/13/2011 | CN101199804B Powders medicament for treating wean enuresis |
| 04/13/2011 | CN101085096B Method for extracting cordate houttuynia |
| 04/13/2011 | CN101053641B Baoyuan kidney-invigorating navel plaster |
| 04/12/2011 | CA2458035C Quaternary ammonium salts of omega-aminoalkylamides of r-2-aryl-propionic acids and pharmaceutical compositions containing them |
| 04/12/2011 | CA2430282C Use of substituted 6-dimethylaminomethyl-1-phenylcyclohexane compounds for treating urinary incontinence |
| 04/12/2011 | CA2354054C Oral administration of lactobacillus for the treatment and prevention of urogenital infection |
| 04/07/2011 | WO2011041697A1 Method of calculating a phosphorus-protein ratio |